Relative bradycardia in patients with covid-19

HIGHLIGHTS

• who: Lae-Young Jung from the , in a tertiary care referral hospitalExclusion criteria were as follows: age below , years, history of specific arrhythmias (atrial fibrillation, sick sinus syndrome, atrioventricular block), treatment with heart rate-lowering medications (e_g, non-dihydropyridine calcium channel blockers or beta blockers), and bradycardia associated with other specific medical conditions (e_g, electrolyte imbalance). The data were reviewed by trained physicians. The study protocol was reviewed and approved by the institutional review board (IRB) of Jeon-buk National University Hospital (IRB Number have published the research: Relative bradycardia in patients with COVID-19, in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.